Market Overview:
The global hydroxychloroquine sulfate tablets market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of autoimmune diseases, growing geriatric population, and rising demand for generic drugs. Based on type, the global hydroxychloroquine sulfate tablets market is segmented into 100 mg and 200 mg. The 100 mg segment is expected to account for a larger share of the market in 2018 owing to its lower price point as compared to 200 mg tablets. However, the 200 mg segment is projected to grow at a higher CAGR during the forecast period due its greater efficacy in treating autoimmune diseases. Based on application, the global hydroxychloroquine sulfate tablets market is segmented into hospital pharmacies and retail pharmacies. The hospital pharmacies segment accounted for a larger share of the market in 2017 and is projected to grow at a higher CAGR duringthe forecast period owingtoits growing demand from hospitals across regions.
Product Definition:
Hydroxychloroquine sulfate is a medication used to treat malaria, lupus, and rheumatoid arthritis. It is taken by mouth. Hydroxychloroquine sulfate may increase the risk of death when used to treat malaria in people who are younger than 18 years old.
100 mg:
Hydroxychloroquine sulfate tablets are used for the treatment of viral diseases such as malaria, typhoid, and yellow fever. It is also used to treat lupus and rheumatoid arthritis. The drug was approved by the FDA in 1951 for the treatment of malaria; it gained widespread recognition in South Africa during Apartheid when doctors were forced to prescribe it due to government restrictions on the use of foreign drugs.
200 mg:
200 mg is used for the treatment of malaria and other diseases caused by P. falciparum and P. malariae, such as vivax, vivianxin, anophelinsinii; chloroquine-resistant malarial parasites in humans; and tetracycline-resistant bacterial infections in animals (such aswiseburnus). It is also used to treat symptoms of sickle cell disease (eg.
Application Insights:
The other application segment includes personal care products, dietary supplements and pharmaceuticals. The demand for the drug in the personal care industry is expected to witness growth at a CAGR of XX% from 2018 to 2030 owing to its benefits as an antioxidant and free radical scavenger. It has been used traditionally for skin conditions such as acne, chickenpox, warts and eczema; however, there are no hydroxychloroquine sulfate tablets available for sale in the market currently.
Dietary supplements are anticipated to be one of the fastest-growing segments over the forecast period due to rising awareness about healthy lifestyle practices among consumers globally. Moreover, increasing health consciousness is likely drive consumer preference toward herbal/natural alternatives that do not contain any side effects or drug interactions which may hamper market growth over time if proper safety standards are not adhered upon during manufacturing process of these tablets (i.e., extraction solvent selection).
Regional Analysis:
North America was the largest market for hydroxychloroquine sulfate tablets, accounting for a share of more than 35.0% in 2017. The region is expected to continue its dominance over the forecast period as well owing to increasing prevalence of malaria and other mosquito-borne illnesses in U.S., which is one of the major drivers responsible for increased demand for Hydroxychloroquine Tablets 100 mg & 200 mg dosage form.
Asia Pacific is anticipated to be one of the fastest growing regions with a CAGR close to 6% during the forecast period due to rising incidence rates of malaria and other mosquito-borne diseases such as dengue, Zika virus disease, etc., especially in India and China. In addition, increasing number hospitals that are purchasing these products from pharmacies will also drive growth over this region during the forecast period (2018 - 2030).
Growth Factors:
- Increasing prevalence of autoimmune diseases: The global Hydroxychloroquine Sulfate Tablets market is expected to grow at a CAGR of XX% during the forecast period owing to the increasing prevalence of autoimmune diseases.
- Rising awareness about hydroxychloroquine sulfate tablets: There is a rising awareness among people about the benefits of hydroxychloroquine sulfate tablets, which is expected to drive the growth of this market in the coming years.
- Technological advancements in drug delivery systems: The development and commercialization of novel drug delivery systems are likely to boost the growth prospects for this market in the near future.
- Growing demand for off-label indications: The demand for hydroxychloroquine sulfate tablets for off-label indications is growing rapidly, which is anticipated to create lucrative opportunities for players operating in this market over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxychloroquine Sulfate Tablets Market Research Report
By Type
100 mg, 200 mg
By Application
Hospital, Pharmacy, Other
By Companies
Teva Pharmaceutical Industries Ltd., Mylan, Novartis, Hikma Pharmaceuticals, Ipca Laboratories, Shanghai Pharmaceuticals Holding Co., Ltd., Sanofi, Taj Pharmaceuticals Limited, Cinkate Corporation, Concordia Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxychloroquine Sulfate Tablets Market Report Segments:
The global Hydroxychloroquine Sulfate Tablets market is segmented on the basis of:
Types
100 mg, 200 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries Ltd.
- Mylan
- Novartis
- Hikma Pharmaceuticals
- Ipca Laboratories
- Shanghai Pharmaceuticals Holding Co., Ltd.
- Sanofi
- Taj Pharmaceuticals Limited
- Cinkate Corporation
- Concordia Healthcare
Highlights of The Hydroxychloroquine Sulfate Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 100 mg
- 200 mg
- By Application:
- Hospital
- Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxychloroquine Sulfate Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxychloroquine sulfate tablets are a medication used to treat malaria. They work by stopping the growth of the parasite in your body.
Some of the key players operating in the hydroxychloroquine sulfate tablets market are Teva Pharmaceutical Industries Ltd., Mylan, Novartis, Hikma Pharmaceuticals, Ipca Laboratories, Shanghai Pharmaceuticals Holding Co., Ltd., Sanofi, Taj Pharmaceuticals Limited, Cinkate Corporation, Concordia Healthcare.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxychloroquine Sulfate Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxychloroquine Sulfate Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxychloroquine Sulfate Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxychloroquine Sulfate Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxychloroquine Sulfate Tablets Market Size & Forecast, 2018-2028
4.5.1 Hydroxychloroquine Sulfate Tablets Market Size and Y-o-Y Growth
4.5.2 Hydroxychloroquine Sulfate Tablets Market Absolute $ Opportunity
Chapter 5 Global Hydroxychloroquine Sulfate Tablets Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
5.2.1 100 mg
5.2.2 200 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hydroxychloroquine Sulfate Tablets Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxychloroquine Sulfate Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxychloroquine Sulfate Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hydroxychloroquine Sulfate Tablets Analysis and Forecast
9.1 Introduction
9.2 North America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
9.6.1 100 mg
9.6.2 200 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hydroxychloroquine Sulfate Tablets Analysis and Forecast
10.1 Introduction
10.2 Europe Hydroxychloroquine Sulfate Tablets Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
10.6.1 100 mg
10.6.2 200 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hydroxychloroquine Sulfate Tablets Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hydroxychloroquine Sulfate Tablets Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
11.6.1 100 mg
11.6.2 200 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hydroxychloroquine Sulfate Tablets Analysis and Forecast
12.1 Introduction
12.2 Latin America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
12.6.1 100 mg
12.6.2 200 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hydroxychloroquine Sulfate Tablets Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hydroxychloroquine Sulfate Tablets Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hydroxychloroquine Sulfate Tablets Market Size Forecast by Type
13.6.1 100 mg
13.6.2 200 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hydroxychloroquine Sulfate Tablets Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxychloroquine Sulfate Tablets Market: Competitive Dashboard
14.2 Global Hydroxychloroquine Sulfate Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceutical Industries Ltd.
14.3.2 Mylan
14.3.3 Novartis
14.3.4 Hikma Pharmaceuticals
14.3.5 Ipca Laboratories
14.3.6 Shanghai Pharmaceuticals Holding Co., Ltd.
14.3.7 Sanofi
14.3.8 Taj Pharmaceuticals Limited
14.3.9 Cinkate Corporation
14.3.10 Concordia Healthcare
